Trial Profile

Phase 2 study of KB 301 for the treatment of wrinkles and improvements in skin quality attributes

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 13 May 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

06 May 2025 According to a Krystal Biotech media release, the company Jeune Aesthetics expects to align with the FDA on the scale and enroll the first subject in a multi-center, randomized, placebo-controlled Phase 2 study evaluating KB301 for the treatment of dynamic wrinkles of the decollete in Q4 2025.
28 Aug 2024 According to Jeune Aesthetics media release, Decollete indication selected for Phase 2 study expected to start next year.
28 Aug 2024 According to Jeune Aesthetics media release, the company announced that on the basis of the strong results of Cohort 4 from Pearl-1, it will be progressing KB301 into Phase 2 development for the treatment of dynamic wrinkles of the decollete, and will be meeting with the FDA in the coming months to enable initiation of the Phase 2 study next year.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com